Public COA audit

Ipamorelin

Audited September 5, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
88
Confidence
92%
Panels
3/7
Purity (printed)
99.9%

Scored high because the document is mostly consistent but carries soft concerns, limited panel coverage (3/7), and 1 soft concern. To improve: include identity, purity, and endotoxin at minimum.

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
CRIPA-10-2604-1
Identity method
LC-MS
Sample date
2026-05-15
Issue date
2026-05-18

Original certificate

Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.

Loading original certificate…

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

3 of 7 present · 3 passed · 0 failed · 0 reported · 4 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    Ipamorelin confirmed

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.90% average (vials: 99.88%, 99.91%, 99.87%, 99.93%)

  • Heavy metals

    Not on this certificate file

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Microbial

    Not on this certificate file

    Bioburden / microbial limits testing.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Endotoxin

    Tested · passed · core

    LAL or chromogenic endotoxin assay.

    Pass (2 replicates, sensitivity ≤0.05 EU/mL)

  • Sterility

    Not on this certificate file

    Sterility testing where applicable.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Residual solvent / water

    Not on this certificate file

    Residual solvents or water content limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing on this file

Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High purity confirmed

    Average purity 99.90% across 4 vials (range 99.87-99.93%) by HPLC-UV. Clean chromatogram with single dominant peak. High purity is normal for research peptides.

  • Identity confirmed by LC-MS

    Mass spectrometry confirms Ipamorelin identity with expected molecular ion peaks shown in mass spectrum.

  • Batch/lot number present

    Lot CRIPA-10-2604-1 clearly documented with accession number 2605150274 and search code Crus2605150274.

  • Dates documented and valid

    Received 2026-05-15, reported 2026-05-18 (3-day turnaround). Both dates are on or before today (2026-09-05).

  • Lab identified with contact info

    Freedom Diagnostics Testing with website FreedomDiagnosticsTesting.com and email [email protected]. Signed by Principal Chemist. USA-based operation claimed.

  • Endotoxin testing performed

    LAL assay per USP <85> with two replicates both passing at sensitivity ≤0.05 EU/mL. Appropriate for injectable research peptides.

  • Limited panel scope

    COA includes identity, purity, net content, and endotoxin testing. Does not include heavy metals, microbial contamination, sterility, or residual solvents/water content. This is common for basic peptide testing but more comprehensive panels may be needed for certain applications.

  • Professional presentation

    Well-formatted document with clear sections, chromatogram, mass spectrum, QR code, and appropriate research-use-only disclaimers. Multiple vials tested showing consistency.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.